@ClaraChan94, HMTM stands for "Hydromethylthionine Mesylate", it is the latest drug being used for Phase 3 trials for Taurx. It is an upgraded version of "Methylthioninium Chloride (MTC)" that was used for the previous trials.
Genting-backed TauRx to seek regulatory approval for Alzheimer's drug ----06 Oct 2022, 10:53 pm
TauRx could contribute RM1.3 billion to RM4.3 billion to Genting’s earnings in the financial year ending Dec 31, 2024 (FY24) to FY26, assuming a 10% net margin, the research house said.
“It could also fetch an upside of RM3.47-13.88/share based on 10x P/E (c.35% discount to peers’ average) on our base and bull cases for FY24F earnings, which translates to hypothetical TPs (target prices) of MYR9.84-20.25 for Genting,” said RHB.
Maybank IB says Genting’s target price could be raised to RM8.86 if TauRX gains FDA approval for Alzheimer’s drug -----01 Feb 2023, 02:26 pm
“Should HMTM be approved, TauRX be ascribed US$15 billion valuation and assuming nil holding company discount, we estimate that our Genting Bhd SOP-based TP may be revised to RM8.86 which would translate into a whopping 79% upside potential,” said Maybank IB, which currently has a “buy” call on the stock and increased its TP a tad to RM5.64 from RM5.59.
If TauRx is worth US$15 billion, Genting will be worth a much higher RM8.57/share,” it said. On its shareholding, it understands that in the last round of TauRx’s rights issue in November 2021, Genting was awarded warrants with an exercise price of US$45 each.
“From other channel checks, we understand that TauRx shares are now transacting at a much higher US$200-US$300 each. We are told that since not all shareholders participated in the aforementioned rights issue and thus, did not receive the warrants, Genting may effectively get to raise its shareholding in TauRx from 20% for cheap,” it said. --------------
Nov 2021 Rights issue was at USD30/share. Nov 2022 Warrant exercise was at USD45/share. Now reportedly transacting at USD200 to 300/share. When a rare opportunity comes, its time to strike it very hard!
Posted by AngTayKor > 2023-05-16 23:46 | Report Abuse
........ ...... I find online trolls very stooopid and lack the ability to further improve themselves. When ATK meet successful investors and stock traders, ATK pluck up courage be "thick-skin" and go chat up with them, be their friend. You will be surprised how friendly and helpful they usually are. Most of them are willing to share if they like you and find you trustworthy. I ask them questions and learn. What is their view? How did they do it? Whats in their mind when they are putting in big investments or when they are trading a large position? Just look around you Im sure you can find some trustworthy mentors you have met before and can learn from them. ATK is also a human. I have my own internal demons (greed and fear) when I trade stocks or invest in Taurx. ------------
Online trolls BS spinning lies here doing fear mongering hoping to buy cheap, bought liow start promoting the stock non-stop hoping to sell higher. These trolls are too lazy to learn some real skill, dont bother to find out how successful traders "Immediately buy, Immediately huat". How professionals are able to do it consistently? How people tripled their Taurx shareholdings during recent Rights and warrant exercise at USD30 to USD45/share, value now at USD200 to 300/share and sitting on multiple fold profit within a short duration. How did they did it?
Professional has an advice for amateur online trolls: "The game of speculation is the most uniformly fascinating game in the world, but it is not a game for the stoopid, the mentally lazy, the person of inferior emotional balance, or for the get-rich-quick adventurer. They will die poor."
Pick up in Genting Malaysia's ops reaffirms recovery KUALA LUMPUR: Genting Malaysia Bhd's key Malaysian operations are seeing the return of tourist arrivals, with operating capacity largely returning to pre-pandemic levels, says CGS-CIMB Research.
Following a weekend visit to Genting Malaysia's Resorts World Genting, the research firm said it reaffirmed its thesis that the continued recovery of the key Malaysian operations will drive a robust three-year earnings per share cumulative aggregate growth rate (CAGR) of 42% in FY22-25.
The Malaysian operations are key contributors to the group's revenue, accounting for 62% of total revenue in 1H23, said CGS-CIMB.
"We observed non-gaming activities, such as restaurant dining and indoor theme park (i.e. Skytropolis), were largely packed and the outdoor (SkyWorlds) theme park was busy with ongoing promotional campaigns.
On World's Alzheimers Day, the corrupted lobbying group Alzheimers Association is still promoting for amyloid drugs non-stop. These drugs are just symptomatic drugs that perform worse than old symptomatic drugs like Aricept. Totally no mention amyloid drug's brain bleeding capabilities, no decrease in NfL biomarker, accelerated brain shrinkage capabilities.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....